These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 24229717

  • 1. Burden of human papillomavirus infection and related diseases in Israel.
    Shavit O, Roura E, Barchana M, Diaz M, Bornstein J.
    Vaccine; 2013 Nov 22; 31 Suppl 8():I32-41. PubMed ID: 24229717
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Nov 22; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [Abstract] [Full Text] [Related]

  • 3. Cancers attributable to human papillomavirus infection.
    Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.
    Sex Health; 2010 Sep 22; 7(3):244-52. PubMed ID: 20719211
    [Abstract] [Full Text] [Related]

  • 4. Global burden of human papillomavirus and related diseases.
    Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F1-31. PubMed ID: 24331745
    [Abstract] [Full Text] [Related]

  • 6. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.
    Vaccine; 2013 Dec 29; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [Abstract] [Full Text] [Related]

  • 7. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R, Mahale P, Sonawane K, Sikora AG, Chhatwal J, Schmeler KM, Sigel K, Cantor SB, Chiao EY, Deshmukh AA.
    JAMA Netw Open; 2018 Sep 07; 1(5):e181999. PubMed ID: 30646145
    [Abstract] [Full Text] [Related]

  • 8. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
    Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J.
    Int J Cancer; 2012 Nov 01; 131(9):1969-82. PubMed ID: 22623137
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [Abstract] [Full Text] [Related]

  • 10. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK.
    J Natl Cancer Inst; 2013 Feb 06; 105(3):175-201. PubMed ID: 23297039
    [Abstract] [Full Text] [Related]

  • 11. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
    Ortiz AP, Engels EA, Nogueras-González GM, Colón-López V, Soto-Salgado M, Vargas A, Machin M, Shiels MS.
    Cancer; 2018 Dec 01; 124(23):4520-4528. PubMed ID: 30345506
    [Abstract] [Full Text] [Related]

  • 12. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM, Louie KS, Clifford G.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [Abstract] [Full Text] [Related]

  • 14. Barriers to human papillomavirus vaccine acceptability in Israel.
    Fisher WA, Laniado H, Shoval H, Hakim M, Bornstein J.
    Vaccine; 2013 Nov 22; 31 Suppl 8():I53-7. PubMed ID: 24229720
    [Abstract] [Full Text] [Related]

  • 15. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.
    J Natl Cancer Inst; 2010 Mar 03; 102(5):325-39. PubMed ID: 20139221
    [Abstract] [Full Text] [Related]

  • 16. Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer.
    Shavit O, Raz R, Stein M, Chodick G, Schejter E, Ben-David Y, Cohen R, Arbel D, Shalev V.
    Appl Health Econ Health Policy; 2012 Mar 01; 10(2):87-97. PubMed ID: 22201263
    [Abstract] [Full Text] [Related]

  • 17. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
    Sand FL, Munk C, Jensen SM, Svahn MF, Frederiksen K, Kjær SK.
    Cancer Epidemiol Biomarkers Prev; 2016 Jul 01; 25(7):1090-7. PubMed ID: 27358257
    [Abstract] [Full Text] [Related]

  • 18. Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel.
    Schejter E, Bornstein J, Siegler E.
    Vaccine; 2013 Nov 22; 31 Suppl 8():I42-5. PubMed ID: 24229718
    [Abstract] [Full Text] [Related]

  • 19. The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.
    Goodman E, Reuschenbach M, Viering T, Luzak A, Greiner W, Hampl M, Jacob C.
    Arch Gynecol Obstet; 2024 Nov 22; 310(5):2639-2646. PubMed ID: 39230793
    [Abstract] [Full Text] [Related]

  • 20. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    Lekoane KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG.
    BMC Cancer; 2019 Jun 11; 19(1):563. PubMed ID: 31185951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.